Sector & Sovereign Research

A new type of cholesterol drug in development by Amgen, Inc. (NASDAQ: AMGN) and another by Sanofi SA (ADR) (NYSE: SNY) with Regeneron Pharmaceuticals Inc (NASDAQ: REGN) may be "very expensive," according to a report in The Wall Street Journal. The new drugs are expected to be...